External Source

Nkg2d Car-t Cell Therapy In Aml/mds

2021 2:00
Synopsis
David Sallman, MD, Moffitt Cancer Center, Tampa, FL, discusses the preliminary findings of two clinical trials of CYAD-01, ...

You Might Also Like

NKG2D-based CAR-T in R/R AML and MDS 2:21
Nkg2d-based Car-t In R/r Aml And Mds
2020
CYCLE-1: next generation NKG2D-based CAR T-cells in AML/MDS 2:29
Cycle-1: Next Generation Nkg2d-based Car T-cells In Aml/mds
2021
CAR T Cell Therapy in MDS/AML 1:31:25
Car T Cell Therapy In Mds/aml
2021
NKG2D CARs for R/R AML and MDS 1:47
Nkg2d Cars For R/r Aml And Mds
2019
THINK trial: Phase I results for NKG2D CAR-T therapy in AML 4:03
Think Trial: Phase I Results For Nkg2d Car-t Therapy In Aml
2019
Insights into NKG2D-targeting CAR-T cells in R/R AML 1:30
Insights Into Nkg2d-targeting Car-t Cells In R/r Aml
2023
David Sallman, MD, offers details regarding the clinical investigation of CYAD-01 2:07
David Sallman, Md, Offers Details Regarding The Clinical Inv...
2021
Hurdles to CAR-T therapy for MDS & AML: T-cell fitness & lack of a uniform target antigen 1:16
Hurdles To Car-t Therapy For Mds & Aml: T-cell Fitness & Lac...
2023
Recent advances in CAR-T therapy for MDS 2:40
Recent Advances In Car-t Therapy For Mds
2022
CAR-T - A Potential in Myeloid Cancers? - K Cummins 21:30
Car-t - A Potential In Myeloid Cancers? - K Cummins
2021
Challenges to Overcome With CAR T-Cell Therapy for Acute Myeloid Leukemia 1:29
Challenges To Overcome With Car T-cell Therapy For Acute Mye...
2018
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.